메뉴 건너뛰기




Volumn 24, Issue 2, 2014, Pages 618-623

Structure-activity relationship study of BACE1 inhibitors possessing a chelidonic or 2,6-pyridinedicarboxylic scaffold at the P2 position

Author keywords

Secretase; Alzheimer's disease; BACE1; BACE1 inhibitor

Indexed keywords

BETA SECRETASE; BETA SECRETASE INHIBITOR; CHELIDONINE; DICARBOXYLIC ACID DERIVATIVE; HALOGEN; KMI 1303; PYRIDINE DERIVATIVE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; BETA SECRETASE 1; BETA SECRETASE 1 INHIBITOR; DIPICOLINIC ACID; HETEROCYCLIC COMPOUND; KMI 1040; KMI 1263; KMI 1331; KMI 789; KMI 827; KMI 848; KMI 870; KMI 871; KMI 876; KMI 886; KMI 887; KMI 898; KMI 899; KMI 900; KMI 902; KMI 903; KMI 911; KMI 922; KMI 923; KMI 926; KMI 943; KMI 991; MOLECULAR SCAFFOLD; UNINDEXED DRUG;

EID: 84891838233     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2013.12.007     Document Type: Article
Times cited : (11)

References (29)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.